Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Prochlorperazine
Compazine · Stemetil · PERPHENAZINE BASE · 6140rp · rp6140 · 6140 RP · Emelent · Nipodal

식별자 및 물리적 특성
| CAS No. | 58-38-8 |
|---|---|
| 분자식 | C20H24ClN3S |
| 평균 분자량 | 373.9 g/mol |
| 단동위원소 질량 | 373.13794645 g/mol |
| SMILES | CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1 |
| InChIKey | WIKYUJGCLQQFNW-UHFFFAOYSA-N |
| PubChem CID | 4917 |
| ChEMBL | CHEMBL728 |
| ChEBI | CHEBI:8435 |
| EC No. | 200-379-4 |
| DTXSID | DTXSID7023514 |
화학 및 물리적 성질
| XLogP | 4.9 |
|---|---|
| 극성 표면적 | 35 |
| 수소 결합 공여자 수 | 0 |
| 수소 결합 수용자 수 | 4 |
| 회전 가능 결합 수 | 4 |
| 무거운 원자 수 | 25 |
| 형식 전하 | 0 |
| 복잡도 | 429 |
| 의약품 | DEA NFLIS-Drug Category -> Depressants and TranquilizersPharmaceuticalsPharmaceuticals -> Listed in ZINC15 |
| LogP(분배 계수) | log Kow = 4.884.64.79 |
| Color/Form | Viscous liquid |
| 용해도 | Freely soluble in alcohol, ether, chloroformIn water, 1.496X10-2 g/L (14.96 mg/L) at 24 °C1.10e-02 g/L클로로포름(약간 용해됨), 에틸아세테이트(약간 용해됨), 메탄올(약간 용해됨) |
| Human Drugs | Breast FeedingLactationMilk, HumanAntiemeticsPhenothiazinesGastrointestinal AgentsFDA approved drugs -> Active ingredientPharmaceuticals |
| Decomposition | When heated to decomposition it emits very toxic fumes of sulfoxides, nitroxides, and /hydrogen chloride/. |
| 녹는점 | 228 °C |
| Physical Description | Solid |
| Stability/Shelf Life | SENSITIVE TO LIGHT. |
| Dissociation Constants | 8.1pKa = 8.1 |
| Collision Cross Section | 183.7 Ų [M+H]+ [CCS Type: TWMethod: Major Mix IMS/Tof Calibration Kit (Waters)] |
| Other Experimental Properties | Minute crystalsSolubility in water: less than 0.1% at 20 °Cslightly soluble in methanol, ethanolpractically insoluble in ether, benzene, chloroformMP: 228 °C /Prochlorperazine dimaleate/White to very light yellow crystalline powder1 g is soluble in about 2 mL water, in about 1500 mL alcoholinsoluble in ether, chloroformodorlesssolutions are acidic to litmus /Edisylate/White or pale yellow crystalline powderalmost completely odorlesssaturated solution is acidic to litmuspractically insoluble in water and ethanolslightly soluble in warm chloroform /Dimaleate/ |
| 끓는 점 | 260-275 °C(Press: 2 Torr) |
| 밀도 | 1.1679 (rough estimate) |
| 굴절률 | 1.6000 (estimate) |
| 저장 조건 | Refrigerator |
| pKa(산도 계수) | pKa 8.1(H2O,t =24±1,I undefined) (Uncertain) |
| 물리적 상태 | 고체 |
| 색상 | 흰색에서 노란색으로 |
| 용해도 | 14.96mg/L(24℃) |
| BCS Class | 2 |
| InChI | InChI=1S/C20H24ClN3S/c1-22-11-13-23(14-12-22)9-4-10-24-17-5-2-3-6-19(17)25-20-8-7-16(21)15-18(20)24/h2-3,5-8,15H,4,9-14H2,1H3 |
| InChIKey | WIKYUJGCLQQFNW-UHFFFAOYSA-N |
| SMILES | C1=C2C(SC3=C(N2CCCN2CCN(C)CC2)C=CC=C3)=CC=C1Cl |
| NIST | Prochlorperazine(58-38-8) |
안전 및 규제
| GHS 분류 | WarningH302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]P203, P260, P261, P263, P264, P270, P271, P280, P301+P317, P304+P340, P318, P319, P330, P403+P233, P405, and P501 (click each P-code to see the statement)The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory. |
|---|---|
| 규제 정보 | Hazard Traits - BioaccumulationEnvironmental Persistence |
| 기타 안전 정보 | IMAP assessments - 10H-Phenothiazine, 2-chloro-10-[3-(4-methyl-1-piperazinyl)propyl]-: Human health tier I assessment |
| FDA 요건 | The Approved Drug Products with Therapeutic Equivalence Evaluations List identifies currently marketed prescription drug products, including prochlorperazine, approved on the basis of safety and effectiveness by FDA under sections 505 of the Federal Food, Drug, and Cosmetic Act.The Approved Drug Products with Therapeutic Equivalence Evaluations List identifies currently marketed prescription drug products, including prochlorperazine edisylate, approved on the basis of safety and effectiveness by FDA under sections 505 of the Federal Food, Drug, and Cosmetic Act. /Prochlorperazine edisylate/The Approved Drug Products with Therapeutic Equivalence Evaluations List identifies currently marketed prescription drug products, including prochlorperazine maleate, approved on the basis of safety and effectiveness by FDA under sections 505 of the Federal Food, Drug, and Cosmetic Act. /Prochlorperazine maleate/The Generic Animal Drug and Patent Restoration act requires that each sponsor of an approved animal drug must submit to the FDA certain information regarding patents held for the animal drug or its method of use. The Act requires that this information, as well as a list of all animal drug products approved for safety and effectiveness, be made available to the public. Prochlorperazine dimaleate is included on this list. /Prochlorperazine dimaleate/For more FDA Requirements (Complete) data for Prochlorperazine (9 total), please visit the HSDB record page. |
| Hazard Classes and Categories | Acute Tox. 4 (100%) |
| Skin, Eye, and Respiratory Irritations | May cause irritation /to the eyes, skin, and mucous membranes/. Avoid inhalation. Remove to fresh air. Avoid contact. Flush /eyes/ with copious quantities of water for at least 15 minutes. Avoid /skin/ contact. Flush with copious quantities of soap and water. |
용도
용도
Prochlorperazine is antiemetic, antipsychotic; used in treatment of vertigo.